 | This biographical article is written like a résumé .(July 2009) |
Edmund Taylor Pratt Jr. | |
|---|---|
| Born | 1927 |
| Died | September 5, 2002 |
| Alma mater | Duke University (B.S.) University of Pennsylvania (M.B.A.) |
| Occupation(s) | Chairman and CEO of Pfizer |
Edmund T. Pratt Jr. (1927 - September 5, 2002) was the Chairman and CEO of Pfizer Inc. He served as President from 1971 to 1972, CEO from 1972 to 1991, and Chairman from 1972 to 1992. [1] He is the namesake of Duke University's Engineering School.
Pratt was born in Savannah, Georgia in 1927 and grew up in Elkton, Maryland. [2] His father worked for the Army Corps of Engineers [3] He graduated from Duke University in 1947 magna cum laude with a bachelor of science in electrical engineering. He also obtained an MBA from University of Pennsylvania's Wharton School of Business in 1949. [4] [5]
Pratt began his career at IBM in 1949. His time at IBM was interrupted for two years when he served with the Navy as a lieutenant during the Korean War. Afterwards, he returned to IBM in 1952, eventually serving as controller of IBM World Trade Corporation from 1958 to 1962. [6] Pratt then joined the Kennedy Administration as assistant secretary of the Army for Financial Management. [7]
After leaving the government in 1964, Pratt joined Pfizer as controller. In 1969, he became chairman and president of Pfizer International. In 1971, he was elected president of Pfizer, and in 1972 he succeeded John Powers, Jr. as chairman and CEO.
During Pratt's two decades at the helm, Pfizer evolved into one of the fastest-growing pharmaceutical companies in the United States. Pratt expanded research and development facilities worldwide, acquired Howmedica and other medical device companies, and introduced of products like Procardia, Feldene, Diflucan, and Norvasc. Under his leadership, annual revenue increased sevenfold, from $1 billion to nearly $7 billion. [8]
Pratt's earlier government service in Washington stood him in good stead as the Company grew and played a greater role in national and international matters. As advisor to United States Trade Representative Bill Brock in the mid-1980s, he played an instrumental role encouraging private sector involvement in trade matters. As chairman of the presidentially appointed Advisory Committee for Trade Negotiations, he also broadened the trade agenda to include items of global impact, including the issue of intellectual property as a result of Pfizer's diminishing returns. In his own words "We were beginning to notice that we were losing market share [in developing countries] because our intellectual property rights were not being respected in these countries" [9] A member of the IPC trade delegation in the Punta del Este round of the GATT trade talks in 1986, he pushed hard for the creation of a commercially beneficial system of worldwide IP rights.
Pratt served as chairman of the Business Council of New York State, The Business Round Table, and the President's Advisory Committee for Trade Negotiations. On March 1, 1992, Pratt retired as chairman and continued his involvement with the Company as a director of the board until 1997.
During his tenure as head of Pfizer, Ed Pratt was instrumental in the creation of low-income housing around Pfizer's Brooklyn plant, the donation of a Pfizer building for a public charter school, and the economic development and improvements in neighborhood safety. He also held leadership positions in organizations such as the United Way, the Boys Clubs of America, and the Girl Scouts of the USA. He made significant contributions to Long Island University, in 1998, to fund academic, computer, and library facilities and, in 1999, to Duke University which created the Pratt School of Engineering.
Pratt was inducted into the Junior Achievement U.S. Business Hall of Fame in 1999. In 1987, he received The Hundred Year Association of New York's Gold Medal Award "in recognition of outstanding contributions to the City of New York."
A magna cum laude graduate of Duke - who relied on a U.S. Navy scholarship to fund his education - Pratt donated $35 million to the university in 1999.
Pratt died of cancer on September 5, 2002, at the age of 75.
He was married to Nancy Rhodes Pratt and had two sons, Randolph and Keith. [10]
The Pratt School of Engineering is located at Duke University in the United States. The school's associated research, education, alumni and service-to-society efforts are collectively known as Duke Engineering.
Louis Vincent Gerstner Jr. is an American businessman, best known for his tenure as chairman of the board and chief executive officer of IBM from April 1993 until 2002, when he retired as CEO in March and chairman in December. He is largely credited with turning IBM's fortunes around.
Samuel J. "Sam" Palmisano is a former president and the eighth chief executive officer of IBM until January 2012. He also served as Chairman of the company until October 1, 2012.
John Thomas Chambers is the former executive chairman and CEO of Cisco Systems.
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
Michael L. Eskew is an American businessman who is the former chairman and chief executive officer of UPS from 2002 to 2007. He is on the board of 3M, IBM, and Eli Lilly and Company.
Jeffrey B. Kindler is an American healthcare executive and private investor. He served as chairman and CEO of the pharmaceutical company Pfizer from 2006 to 2010. Kindler has later served as CEO of Centrexion Inc., and chairman of the GLG Institute.
Sidney Taurel is an American businessman. He is the chairman of Pearson plc and chairman emeritus of Eli Lilly and Company, where he had a 37-year career and served as chairman and chief executive officer from 1998 to 2008. He became chairman of Pearson in January 2016. He is currently a director of IBM Corporation and advises Almirall S.A. on issues of corporate strategy.
James L. "Jim" Vincent was the chairman and CEO of Biogen Idec from 1985 to 2002. He graduated from Duke University's Pratt School of Engineering in 1961 with a Bachelor of Science degree, and received an MBA from the Wharton School of Business at the University of Pennsylvania in 1963. He was a member of the board of directors of Alnylam Pharmaceuticals and served as a trustee of Duke University for 12 years. He had two children, Aimee (Vincent) Jamison and Christopher Vincent.
William C. Weldon is a former chairman of Johnson & Johnson, He was the eighth chairman in Johnson & Johnson's history of more than one hundred years.
Robert Plonsey was the Pfizer-Pratt University Professor Emeritus of Biomedical Engineering at Duke University. He is noted for his work on bioelectricity.
The Economic Club of New York is a U.S. nonprofit and non-partisan membership organization dedicated to promoting the study and discussion of social, economic and political questions.
J. Michael Pearson is a Canadian American pharmaceutical company executive. He is the former chairman and CEO of Valeant Pharmaceuticals International after being ousted in the aftermath of a report on pharmaceutical pricing published by Citron Research in April 2016.
David Ebsworth is non-executive chairman at Verona Pharma Plc. His career spans over 35 years in the global pharmaceutical industry, during which he was Global Head of Pharmaceuticals at Bayer AG and CEO of a number of companies, including ViforPharma and Galenica. He is also an advisor to a variety of CEOs at public and private organisations.
Lawrence Lenihan is an American businessperson. Lenihan began his career at IBM, and became a principal at Broadview Associates. He is the co-founder of Pequot Ventures in 1996, FirstMark Capital in 2008, Norisol Ferrari in 2009, and Resonance in 2015. He has also served as an adjunct professor at New York University’s Leonard N. Stern School of Business, and has sat on boards for companies funded by his venture funds in addition to others.
Albert Bourla is a Greek-American veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.
Mazi Samuel Iheanyichukwu Ohuabunwa, is a Nigerian pharmacist, politician and business executive. He is the founder and former CEO of Neimeth Pharmaceutical. He is a former president of the Pharmaceutical Society of Nigeria.
William C. Steere Jr. is a former chief executive officer of Pfizer. He is also a member of the board of directors of the New York Botanical Garden. While Steere was CEO of Pfizer, the company acquired Warner-Lambert and brought to market blockbuster drugs including Viagra, Zoloft, and Zithromax. His decision to triple research expenditures in 8 years, to $2.2 billion, was cited as a reason for the prosperity of Pfizer during his tenure, a period in which sales of the company doubled.
| International | |
|---|---|
| National | |
